(Q36695246)

15 August 2017

MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate (English)

1 reference

15 August 2017

1 reference

C F Qu

1

1 reference

15 August 2017

Y Li

2

1 reference

15 August 2017

Y J Song

3

1 reference

15 August 2017

S M A Rizvi

4

1 reference

15 August 2017

C Raja

5

1 reference

15 August 2017

D Zhang

6

1 reference

15 August 2017

J Samra

7

1 reference

15 August 2017

R Smith

8

1 reference

15 August 2017

A C Perkins

9

1 reference

15 August 2017

C Apostolidis

10

1 reference

15 August 2017

B J Allen

11

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

91

1 reference

15 August 2017

12

1 reference

15 August 2017

2086-2093

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602232

15 August 2017

0 references

cites work

In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

30 September 2017

Cancer statistics, 1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Molecular biology in radiation therapy: the potential impact of recombinant technology on clinical practice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

The development of monoclonal antibodies for the therapy of cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Monoclonal antibodies to epithelial sialomucins recognize epitopes at different cellular sites in adenolymphomas of the parotid gland.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409789

Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia

5 September 2018

1 reference

12 December 2020

Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast

1 reference

12 December 2020

Radioimmunoconjugates for targeted alpha therapy of malignant melanoma

1 reference

12 December 2020

Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule

1 reference

12 December 2020

Ac-225 and her daughters: the many faces of Shiva

1 reference

12 December 2020

Targeted alpha particle immunotherapy for myeloid leukemia

1 reference

12 December 2020

Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas

1 reference

12 December 2020

The in vivo fate of a 21 211AT labelled monoclonal antibody witknown specificity in a murine system

1 reference

12 December 2020

Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction

1 reference

12 December 2020

Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer

1 reference

12 December 2020

Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients

1 reference

12 December 2020

Can alpha-immunotherapy succeed where other systemic modalities have failed?

1 reference

12 December 2020

Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595

1 reference

12 December 2020

Optimizations of Radiolabeling of Immunoproteins with 213Bi

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602232

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJC.6602232

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

15599383

1 reference